[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335017-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335017-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","blood-derived-extracellular-vesicles-as-a-promising-liquid-biopsy-diagnostic-tool-for-early-cancer-detection","Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection","","Cancer is a major global public health challenge, and timely screening can curb progression and reduce mortality. Early tumor detection currently depends on imaging and invasive tissue biopsies. Non-invasive, low-cost, highly sensitive screening methods are increasingly needed. Extracellular vesicles (EVs) carry nucleic acids, proteins, and lipids, supporting liquid biopsy for diagnosis. Existing obstacles in isolation purification and validation limit broad clinical use, motivating improved techniques and further EV investigations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/blood-derived-extracellular-vesicles-as-a-promising-liquid-biopsy-diagnostic-tool-for-early-cancer-detection/335017/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/blood-derived-extracellular-vesicles-as-a-promising-liquid-biopsy-diagnostic-tool-for-early-cancer-detection/335017.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early cancer screening important?","Question",{"text":63,"@type":64},"Early screening helps mitigate cancer progression and reduce mortality by enabling earlier identification compared with delayed diagnosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What makes liquid biopsy suitable for early cancer detection?",{"text":68,"@type":64},"Liquid biopsy can use extracellular vesicles that contain distinctive biological components, supporting diagnosis while being non-invasive.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges limit the clinical adoption of blood-derived EV-based liquid biopsy?",{"text":72,"@type":64},"Difficulties in isolation/purification methods and insufficient validation of efficacy currently hinder widespread clinical implementation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335017,1790151509,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":4},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","biomolecules  \nReview  \nBlood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection  \nDan He 1,†, Bozhou Cui 2,†, Hongkai Lv 3, Shuxian Lu 1, Yuan Zhu 1, Yuqiang Cheng 3, Lin Dang 4, * and Hong Zhang 1, *  \nCitation: He, D.; Cui, B.; Lv, H.; Lu, S.; Zhu, Y.; Cheng, Y.; Dang, L.; Zhang, H. Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection. Biomolecules 2024, 14, 847. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/biom14070847](10.3390/biom14070847)  \nAcademic Editors: Charles Lawrie and Lucas Treps  \nReceived: 14 April 2024  \nRevised: 27 June 2024  \nAccepted: 1 July 2024  \nPublished: 14 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Laboratory of Animal Center, Medical Experiment Center, Shaanxi University of Chinese Medicine, Xianyang 712046, China; [hedan069@sntcm.edu.cn](hedan069@sntcm.edu.cn) (D.H.); [1471027@sntcm.edu.cn](1471027@sntcm.edu.cn) (S.L.); [1471029@sntcm.edu.cn](1471029@sntcm.edu.cn) (Y.Z.)  \n2 Department of Experimental Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China; [cuibozhou@fmmu.edu.cn](cuibozhou@fmmu.edu.cn)  \n3 Department of Clinical Medicine of Second Clinical Medical School, Shaanxi University of Chinese Medicine, Xianyang 712046, China; [522030101512@email.sntcm.edu.cn](522030101512@email.sntcm.edu.cn) (H.L.); [522030101510@email.sntcm.edu.cn](522030101510@email.sntcm.edu.cn) (Y.C.)  \n4 Basic Medical Academy, Shaanxi University of Chinese Medicine, Xianyang 712046, China  \n* Correspondence: [2111009@sntcm.edu.cn](2111009@sntcm.edu.cn) (L.D.); [1471001@sntcm.edu.cn](1471001@sntcm.edu.cn) (H.Z.)† These authors contributed equally to this work.  \nAbstract: Cancer poses a signiﬁcant public health challenge worldwide, and timely screening has the potential to mitigate cancer progression and reduce mortality rates. Currently, early identiﬁcation of most tumors relies on imaging techniques and tissue biopsies. However, the use of low-cost, highly sensitive, non-invasive detection methods for early cancer screening has become more attractive. Extracellular Vesicles (EVs) released by all living cells contain distinctive biological components, such as nucleic acids, proteins, and lipids. These vesicles play crucial roles in the tumor microenvironment and intercellular communication during tumor progression, rendering liquid biopsy a particularly suitable method for diagnosis. Nevertheless, challenges related topuriﬁcation methods and validation of efﬁcacy currently hinder its widespread clinical implementation. These limitations underscore the importance of reﬁning isolation techniques and conducting comprehensive investigations on EVs. This study seeks to evaluate the potential of liquid biopsy utilizing blood-derived EVs as a practical, cost-effective, and secure approach for early cancer detection.  \nKeywords: blood-derived extracellular vesicles; liquid biopsy; early detection; cancer diagnosis; cancer biomarker  \n1. Introduction  \nAccording to the National Center for Health Statistics, nearly 1670 cancer-related deaths were reported daily in the United States by 2023, which already is a major public health concern [1], driven most signiﬁcantly by delays in diagnosis. Therefore, ﬁnding biomarkers for early cancer screening in the population is of great signiﬁcance. Despite advances in cancer-screening tests that have increased 5-year survival rates from 49% in 2012 to 68% in 2018 [1,2], no study has conducted high-quality screening for early cancer. High-quality cancer screening not only effectively assesses the tumor type, sta","cbCaijoGynJFRnrB","https://ap.wps.com/l/cbCaijoGynJFRnrB","pdf",2865917,"English","# Introduction\n## Need for early cancer screening\n## Limitations of current screening methods\n## Rationale for blood-derived EVs and liquid biopsy","[{\"question\":\"Why is early cancer screening important?\",\"answer\":\"Early screening helps mitigate cancer progression and reduce mortality by enabling earlier identification compared with delayed diagnosis.\"},{\"question\":\"What makes liquid biopsy suitable for early cancer detection?\",\"answer\":\"Liquid biopsy can use extracellular vesicles that contain distinctive biological components, supporting diagnosis while being non-invasive.\"},{\"question\":\"What challenges limit the clinical adoption of blood-derived EV-based liquid biopsy?\",\"answer\":\"Difficulties in isolation/purification methods and insufficient validation of efficacy currently hinder widespread clinical implementation.\"}]","Blood-Derived Extracellular Vesicles as a Promising Liquid Biopsy Diagnostic Tool for Early Cancer Detection | PDF",1790009261]